The first pharmaceutically produced THC-free* extra-strength cannabidiol (CBD) Oakville, Ontario–(Newsfile Corp. – October 20, 2020) – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (“Cardiol” or the “Company“), a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease, is pleased to announce the commercial introduction of CortalexTM, a THC-free* extra-strength (100 mg/mL concentration) oral […]
Trial will take place at major U.S. centers and examine the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, cardiovascular disease (CVD) Oakville, Ontario–(Newsfile Corp. – September 25, 2020) – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (“Cardiol” or the “Company“), a clinical-stage biotechnology company focused […]
Famously known for its vineyards, the rolling hills of Santa Barbara, California and, 200 miles to the north, the Salinas Valley, once the rose capital of the world, have transformed into new commerce hubs: cannabis. As the only areas of California currently allowing large-scale cannabis cultivation, companies looking to get an upper hand on market […]
In the burgeoning cannabis industry, testing companies are often considered the gatekeepers to success. Between consumer demand and regulatory obligations, marijuana producers are compelled to provide a full analysis of what they’re putting on the market and accurate results are crucial. FluroTech (TSX-V: TEST) (OTCQB: FLURF) is a Canadian-based provider of cannabis and hemp testing […]
RYAH Finds Top Priority is Treating Mental Health, Over 28,000 Women Surveyed New York, NY, October 30, 2019 – RYAH Medtech, Inc. (“RYAH” or the “Company”), a big data and technology company focused on valuable predictive analysis in the global medical plant intake industry, has released a data analytics report on women and their medical […]
If a company wants to generate substantial revenue from a tobacco product, it better get into convenience stores. According to the National Association of Convenience Stores (NACS) 2019 State of the Industry Report, conventional cigarette sales are declining, but sales of “other tobacco products” (OTP) are on the rise. In 2018, OTP dollar sales jumped […]
Some cannabis companies choose to employ a shotgun approach to building their brands, launching a wide variety of products in the hopes that some are successful. The team at Plus Products (CSE: PLUS, OTCQB: PLPRF) has taken a more focused approach, guided by an understanding that the most successful companies began by perfecting one thing […]
The negative stigmas attached to cannabis continue to fade away like a puff of smoke in the wind. Most people are now well aware of the therapeutic benefits of the cannabis plant and its cousin hemp. Investors are certainly aware of the massive industry unfolding. Against this backdrop, cannabis operations have moved from the […]
Cannabidiol, or CBD, is the main non-psychotropic active ingredient in cannabis and hemp. In the United States, passage of the 2018 Farm Bill led the federal government to declassify hemp as a dangerous drug, opening the doors for states to implement regulatory programs overseeing legal hemp production and processing. As a result, the CBD-in-everything-you-can-imagine trend […]
After announcing its intent to acquire Solace Management Group Inc. and its suite of brands back in February, British Columbia-based Geyser Brands Inc. (TSXV: GYSR) has just been awarded conditional approval by the TSX, and expects the transaction to be completed by the end of August, pending final approval from the Exchange through a […]
The United States’ federal government, through passage of the Farm Bill in late 2018, in essence removed hemp from its list of dangerous drugs. Since then, states have been formulating regulations for the cultivation, processing, and sales of hemp-derived products, the bulk of which contain cannabidiol, or CBD. Canada is expected to legalize hemp- […]
Hemptown Poised to Profit Following Passage of US Farm Bill Prior to the 2018 US Farm Bill, hemp – defined by the legislation as the cannabis plant containing less than 0.3% THC – carried the same legal classification as THC-rich cannabis, and aside from a handful of pilot projects, the mass production of industrial […]
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.